Mark Devlin

Chief Executive Officer at Aculeus Therapeutics - Melbourne, Victoria, Australia

Mark Devlin's Contact Details
HQ
Location
Melbourne,Victoria,Australia
Company
Aculeus Therapeutics
Mark Devlin's Company Details
Aculeus Therapeutics logo, Aculeus Therapeutics contact details

Aculeus Therapeutics

Melbourne, Victoria, Australia • 6 Employees
Research

Aculeus Therapeutics is a Biotech company based in Melbourne Australia, developing small molecule drugs that modulate the immune system for the treatment of cancer and other serious diseases. Aculeus is doing this by developing drugs that target the Stimulator of Interferon Genes (STING) biochemical pathway.Aculeus in-licensed its lead programs, STING and ENPP1, in 2020 from the CRC for Cancer Therapeutics, a Public Private Partnership between a number of Australia's leading Medical Research Institutes, Universities and Industry partners with a track record of scientific and commercial success.

Details about Aculeus Therapeutics
Frequently Asked Questions about Mark Devlin
Mark Devlin currently works for Aculeus Therapeutics.
Mark Devlin's role at Aculeus Therapeutics is Chief Executive Officer.
Mark Devlin's email address is ***@aculeustx.com. To view Mark Devlin's full email address, please signup to ConnectPlex.
Mark Devlin works in the Research industry.
Mark Devlin's colleagues at Aculeus Therapeutics are Benjamin Morrow, Warwick Tong, Geoff Matthews and others.
Mark Devlin's phone number is
See more information about Mark Devlin